Skip to main content

Caligan Partners LP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1727492 NEW YORK, NY

Position in ANIK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$20,809,385
+$7,017,786 QoQ
Shares Held
1,435,130
0.0% QoQ
Ownership
10.8%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Caligan Partners LP holds $327,216,369 across 2 Drug Manufacturers - Specialty & Generic names. ANIK ranks #2 (6.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ANIK
Anika Therapeutics, Inc.
This page
1,435,130 $20,809,385

All Filings in ANIK

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,809,385 1,435,130
2026-01-23 $13,361,060 1,435,130
2025-12-31 $13,791,599 1,435,130
2025-11-19 $13,662,437 1,435,130
2025-09-30 $13,490,222 1,435,130
2025-06-30 $15,183,675 1,435,130
2025-03-31 $21,570,003 1,435,130
2024-12-31 $23,622,239 1,435,130
2024-09-30 $35,447,711 1,435,130
2024-06-30 $36,373,702 1,435,993
2024-03-31 $36,474,222 1,435,993
2023-12-31 $24,503,617 1,081,360
2023-09-30 $20,145,736 1,081,360
2023-06-30 $18,713,160 720,291
2023-03-31 $20,543,157 715,291
2022-12-31 $17,513,580 591,675